XML 32 R21.htm IDEA: XBRL DOCUMENT v3.19.1
Share Capital (Tables)
 3 Months Ended
Mar. 31, 2019
Equity [Abstract]  
Summary of Stock Option Activity

A summary of the Company’s option activity related to options to employees and directors, and related information is as follows:

 

    For the three months ended March 31, 2019  
    Number of stock options     Weighted average exercise price     Aggregate intrinsic value  
                   
Outstanding at beginning of period     398,308     $ 11.50     $ 108  
Granted     11,630       8.6       -  
Exercised     -       -       -  
Cancelled     -       -       -  
Outstanding at end of period     409,938     $ 11.38     $ 761  
Vested at end of period     265,989     $ 8.95     $ 761  

 

    For the year ended December 31, 2018  
    Number of stock options     Weighted average exercise price     Aggregate intrinsic value  
Outstanding at beginning of period     414,965     $ 11.70     $ 1,859  
Granted     10,000       9       -  
Exercised     (2,487 )     -       -  
Cancelled     (24,170 )     -       -  
Outstanding at end of period     398,308     $ 11.50     $ 108  
Vested at end of period     245,010     $ 8.45     $ 108

Schedule of Stock Options Outstanding

The stock options outstanding as of March 31, 2019 and December 31, 2018, separated by exercise prices, are as follows:

 

Exercise price $   Stock
options
outstanding
as of March
31, 2019		     Stock
options
outstanding
as of
December 31, 2018		     Weighted
average
remaining
contractual
life – years
as of March
31, 2019		     Weighted
average
remaining
contractual
life – years
as of
December
31, 2018		     Stock
options
exercisable
as of March
31, 2019		     Stock
options
exercisable
as of
December
31, 2018		  
                                     
4.20     77,846       77,846       6.75       7.00       77,846       77,846  
15.75     133,546       133,546       8.50       8.75       61,387       53,752  
8.6     11,630       -       9.75       -       2,905       -  
9.00     10,000       10,000       9.50       9.75       2,500       -  
19.35     72,508       72,508       8.50       8.75       34,442       29,003  
15.30     41,866       41,866       8.75       9.00       24,367       21,867  
(*)     62,542       62,542       7.50       7.75       62,542       62,542  
      409,938       398,308       6.75       7.00       265,989       245,010  

 

 

(*)       Less than $0.01.
Schedule of Stock Options Valuation Assumptions

The fair value of the stock options is estimated at the date of grant using Black-Scholes options pricing model with the following weighted-average assumptions:

 

   

Three months ended

March 31, 2019

    

Year ended

December 31, 2018

  
             
Expected volatility     144.4 %     99.4 %
Risk-free interest     1.64 %     2.39 %
Dividend yield     0 %     0 %
Expected life of up to (years)     6.37       5.24

Schedule of Warrants Outstanding

The remaining outstanding warrants and terms as of March 31, 2019 and December 31, 2018 are as follows:

 

Issuance date   Outstanding
as of
December 31, 2018		     Outstanding
as of
March 31, 2019		     Exercise
Price		     Exercisable
as of
March 31, 2019		     Exercisable
Through		  
                               
Series A (2013)     181       181     $ 2,754       181       April 2023  
Series A (2015)     676       676     $ 1,377       676       April 2020  
Series B (2016) (a)     2,741       2,741     $ 40.5       2,741       March 2022